skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study

Original Research

(6301) Views  (888) Full article downloads

Authors: Robert M Shavelle, David R Paculdo, Scott J Kush, David M Mannino, David J Strauss

Published Date March 2009 Volume 2009:4 Pages 137 - 148
DOI: http://dx.doi.org/10.2147/COPD.S5237

Robert M Shavelle1, David R Paculdo1, Scott J Kush1, David M Mannino2, David J Strauss1

1Life Expectancy Project, San Francisco, CA, USA; 2Pulmonary Epidemiology Research Laboratory, University of Kentucky School of Medicine, Division of Pulmonary and Critical Care Medicine, Lexington, KY, USA

Rationale: Previous studies have demonstrated that chronic obstructive pulmonary disease (COPD) causes increased mortality in the general population. But life expectancy and the years of life lost have not been reported.

Objectives: To quantify mortality, examine how it varies with age, sex, and other risk factors, and determine how life expectancy is affected.

Methods: We constructed mortality models using the Third National Health and Nutrition Examination Survey, adjusting for age, sex, race, and major medical conditions. We used these to compute life expectancy and the years of life lost. Measurements and main results: Pulmonary function testing classifi ed patients as having Global Initiative on Obstructive Lung Disease (GOLD) stage 0, 1, 2, 3 or 4 COPD or restriction. COPD is associated with only a modest reduction in life expectancy for never smokers, but with a very large reduction for current and former smokers. At age 65, the reductions in male life expectancy for stage 1, stage 2, and stages 3 or 4 disease in current smokers are 0.3 years, 2.2 years, and 5.8 years. These are in addition to the 3.5 years lost due to smoking. In former smokers the reductions are 1.4 years and 5.6 years for stage 2 and stages 3 or 4 disease, and in never smokers they are 0.7 and 1.3 years.

Conclusions: Persons with COPD have an increased risk of mortality compared to those who do not, with consequent reduction in life expectancy. The effect is most marked in current smokers, and this is further reason for smokers to quit.

Keywords: survival, mortality, longevity, COPD








Readers of this article also read:

Factors affecting health status in COPD patients with co-morbid anxiety or depression
Preferential recruitment of neutrophils by endothelin-1 in acute lung inflammation induced by lipopolysaccharide or cigarette smoke
Markers of early disease and prognosis in COPD
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
The pathophysiology of bronchiectasis
Budesonide/formoterol combination in COPD: a US perspective
Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners
Lung function decline in COPD
The burden of chronic obstructive pulmonary disease among employed adults
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio